{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T23:08:33Z","timestamp":1773788913434,"version":"3.50.1"},"reference-count":100,"publisher":"Baishideng Publishing Group Inc.","issue":"42","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2014]]},"DOI":"10.3748\/wjg.v20.i42.15624","type":"journal-article","created":{"date-parts":[[2014,11,14]],"date-time":"2014-11-14T03:34:16Z","timestamp":1415936056000},"page":"15624","source":"Crossref","is-referenced-by-count":41,"title":["Gut microbiota-related complications in cirrhosis"],"prefix":"10.3748","volume":"20","author":[{"given":"Isabel","family":"G\u00f3mez-Hurtado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Madrid AM, Cumsille F, Defilippi C. Altered small bowel motility in patients with liver cirrhosis depends on severity of liver disease. Dig Dis Sci 1997;42:738-742.","DOI":"10.1023\/A:1018899611006"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Garcia-Tsao G, Wiest R. Gut microflora in the pathogenesis of the complications of cirrhosis. Best Pract Res Clin Gastroenterol 2004;18:353-372.","DOI":"10.1016\/j.bpg.2003.10.005"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Berg RD, Garlington AW. Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model. Infect Immun 1979;23:403-411.","DOI":"10.1128\/IAI.23.2.403-411.1979"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20632"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(97)80474-6"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Guarner C, Soriano G. Bacterial translocation and its consequences in patients with cirrhosis. Eur J Gastroenterol Hepatol 2005;17:27-31.","DOI":"10.1097\/00042737-200501000-00006"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.mi.31.100177.000543"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/nature11550"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003;361:512-519.","DOI":"10.1016\/S0140-6736(03)12489-0"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Dubos R, Schaedler RW, Costello R, Hoet P. Indigenous, normal, and autochthonous flora of the gastrointestinal tract. J Exp Med 1965;122:67-76.","DOI":"10.1084\/jem.122.1.67"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Schaedler RW, Dubos R, Costello R. The development of the bacterial flora in the gastrointestinal tract of mice. J Exp Med 1965;122:59-66.","DOI":"10.1084\/jem.122.1.59"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.01.019"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24423"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.01.003"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2010.10.015"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21838"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.04211.x"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.11.015"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Jalan R, Shawcross D, Davies N. The molecular pathogenesis of hepatic encephalopathy. Int J Biochem Cell Biol 2003;35:1175-1181.","DOI":"10.1016\/S1357-2725(02)00396-5"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-005-7205-0"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Huizenga JR, Gips CH, Tangerman A. The contribution of various organs to ammonia formation: a review of factors determining the arterial ammonia concentration. Ann Clin Biochem 1996;33:23-30.","DOI":"10.1177\/000456329603300103"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50087"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-006-9042-1"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.038679"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Butterworth RF. Pathophysiology of hepatic encephalopathy: a new look at ammonia. Metab Brain Dis 2002;17:221-227.","DOI":"10.1023\/A:1021989230535"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00190.2011"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20194"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-012-9303-0"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00152.2012"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1001061107"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.00797.x"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2009.01022.x"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1000082107"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21533"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199708143370707"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060042"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0b013e32835f43b0"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Solga SF. Probiotics can treat hepatic encephalopathy. Med Hypotheses 2003;61:307-313.","DOI":"10.1016\/S0306-9877(03)00192-0"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-013-9388-0"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Loguercio C, Del Vecchio Blanco C, Coltorti M. Enterococcus lactic acid bacteria strain SF68 and lactulose in hepatic encephalopathy: a controlled study. J Int Med Res 1987;15:335-343.","DOI":"10.1177\/030006058701500602"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Loguercio C, Abbiati R, Rinaldi M, Romano A, Del Vecchio Blanco C, Coltorti M. Long-term effects of Enterococcus faecium SF68 versus lactulose in the treatment of patients with cirrhosis and grade 1-2 hepatic encephalopathy. J Hepatol 1995;23:39-46.","DOI":"10.1016\/0168-8278(95)80309-2"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2013.11.006"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2010.01.006"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22445"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1040322"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-006-9687-y"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2008.01861.x"},{"key":"ref48","unstructured":"Dhiman RK, Chawla YK. Minimal hepatic encephalopathy: time to recognise and treat. Trop Gastroenterol 2008;29:6-12."},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.07.045"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Arora S, Martin CL, Herbert M. Myth: interpretation of a single ammonia level in patients with chronic liver disease can confirm or rule out hepatic encephalopathy. CJEM 2006;8:433-435.","DOI":"10.1017\/S148180350001424X"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24228"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-012-9370-2"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Colombato LA, Albillos A, Groszmann RJ. Temporal relationship of peripheral vasodilatation, plasma volume expansion and the hyperdynamic circulatory state in portal-hypertensive rats. Hepatology 1992;15:323-328.","DOI":"10.1002\/hep.1840150224"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rod&eacute;s J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988;8:1151-1157.","DOI":"10.1002\/hep.1840080532"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Groszmann RJ. Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences. Hepatology 1994;20:1359-1363.","DOI":"10.1002\/hep.1840200538"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Franc&eacute;s R, Mu\u00f1oz C, Zapater P, Uceda F, Gasc&oacute;n I, Pascual S, P&eacute;rez-Mateo M, Such J. Bacterial DNA activates cell mediated immune response and nitric oxide overproduction in peritoneal macrophages from patients with cirrhosis and ascites. Gut 2004;53:860-864.","DOI":"10.1136\/gut.2003.027425"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23918"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Meyer J, Traber LD, Nelson S, Lentz CW, Nakazawa H, Herndon DN, Noda H, Traber DL. Reversal of hyperdynamic response to continuous endotoxin administration by inhibition of NO synthesis. J Appl Physiol (1985) 1992;73:324-328.","DOI":"10.1152\/jappl.1992.73.1.324"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510230644"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"Lopez-Talavera JC, Merrill WW, Groszmann RJ. Tumor necrosis factor alpha: a major contributor to the hyperdynamic circulation in prehepatic portal-hypertensive rats. Gastroenterology 1995;108:761-767.","DOI":"10.1016\/0016-5085(95)90449-2"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2013.12.010"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002147"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510290608"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002907.pub2"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198412203112502"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-944566"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20559"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.07.010"},{"key":"ref69","doi-asserted-by":"crossref","unstructured":"Rimola A, Garc&iacute;a-Tsao G, Navasa M, Piddock LJ, Planas R, Bernard B, Inadomi JM. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol 2000;32:142-153.","DOI":"10.1016\/S0168-8278(00)80201-9"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50038"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12172"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0b013e328351d003"},{"key":"ref73","doi-asserted-by":"crossref","unstructured":"Wiest R, Chen F, Cadelina G, Groszmann RJ, Garcia-Tsao G. Effect of Lactobacillus-fermented diets on bacterial translocation and intestinal flora in experimental prehepatic portal hypertension. Dig Dis Sci 2003;48:1136-1141.","DOI":"10.1023\/A:1023729115659"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12280"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2009.02020.x"},{"key":"ref76","doi-asserted-by":"crossref","unstructured":"Fern&aacute;ndez J, Navasa M, G&oacute;mez J, Colmenero J, Vila J, Arroyo V, Rod&eacute;s J. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 2002;35:140-148.","DOI":"10.1053\/jhep.2002.30082"},{"key":"ref77","doi-asserted-by":"crossref","unstructured":"Caly WR, Strauss E. A prospective study of bacterial infections in patients with cirrhosis. J Hepatol 1993;18:353-358.","DOI":"10.1016\/S0168-8278(05)80280-6"},{"key":"ref78","unstructured":"Yoshida H, Hamada T, Inuzuka S, Ueno T, Sata M, Tanikawa K. Bacterial infection in cirrhosis, with and without hepatocellular carcinoma. Am J Gastroenterol 1993;88:2067-2071."},{"key":"ref79","doi-asserted-by":"crossref","unstructured":"Such J, Runyon BA. Spontaneous bacterial peritonitis. Clin Infect Dis 1998;27:669-74; quiz 675-6.","DOI":"10.1086\/514940"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1007198"},{"key":"ref81","doi-asserted-by":"crossref","unstructured":"Runyon BA, Akriviadis EA, Sattler FR, Cohen J. Ascitic fluid and serum cefotaxime and desacetyl cefotaxime levels in patients treated for bacterial peritonitis. Dig Dis Sci 1991;36:1782-1786.","DOI":"10.1007\/BF01296625"},{"key":"ref82","doi-asserted-by":"crossref","unstructured":"Runyon BA, McHutchison JG, Antillon MR, Akriviadis EA, Montano AA. Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis. A randomized controlled study of 100 patients. Gastroenterology 1991;100:1737-1742.","DOI":"10.1016\/0016-5085(91)90677-D"},{"key":"ref83","doi-asserted-by":"crossref","unstructured":"Rimola A, Salmer&oacute;n JM, Clemente G, Rodrigo L, Obrador A, Miranda ML, Guarner C, Planas R, Sol&aacute; R, Vargas V. Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study. Hepatology 1995;21:674-679.","DOI":"10.1002\/hep.1840210312"},{"key":"ref84","doi-asserted-by":"crossref","unstructured":"Ricart E, Soriano G, Novella MT, Ortiz J, S&agrave;bat M, Kolle L, Sola-Vera J, Mi\u00f1ana J, Ded&eacute;u JM, G&oacute;mez C. Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients. J Hepatol 2000;32:596-602.","DOI":"10.1016\/S0168-8278(00)80221-4"},{"key":"ref85","doi-asserted-by":"crossref","unstructured":"Navasa M, Follo A, Llovet JM, Clemente G, Vargas V, Rimola A, Marco F, Guarner C, Forn&eacute; M, Planas R. Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis. Gastroenterology 1996;111:1011-1017.","DOI":"10.1016\/S0016-5085(96)70069-0"},{"key":"ref86","doi-asserted-by":"crossref","unstructured":"Gin&eacute;s P, Rimola A, Planas R, Vargas V, Marco F, Almela M, Forn&eacute; M, Miranda ML, Llach J, Salmer&oacute;n JM. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology 1990;12:716-724.","DOI":"10.1002\/hep.1840120416"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25532"},{"key":"ref88","doi-asserted-by":"crossref","unstructured":"Guarner C, Runyon BA, Heck M, Young S, Sheikh MY. Effect of long-term trimethoprim-sulfamethoxazole prophylaxis on ascites formation, bacterial translocation, spontaneous bacterial peritonitis, and survival in cirrhotic rats. Dig Dis Sci 1999;44:1957-1962.","DOI":"10.1023\/A:1026649730012"},{"key":"ref89","doi-asserted-by":"crossref","unstructured":"Terg R, Llano K, Cobas SM, Brotto C, Barrios A, Levi D, Wasen W, Bartellini MA. Effects of oral ciprofloxacin on aerobic gram-negative fecal flora in patients with cirrhosis: results of short- and long-term administration, with daily and weekly dosages. J Hepatol 1998;29:437-442.","DOI":"10.1016\/S0168-8278(98)80062-7"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12070"},{"key":"ref91","doi-asserted-by":"crossref","unstructured":"Franc&eacute;s R, Chiva M, S&aacute;nchez E, Gonz&aacute;lez-Navajas JM, Llovet T, Zapater P, Soriano G, Mu\u00f1oz C, Balanz&oacute; J, P&eacute;rez-Mateo M. Bacterial translocation is downregulated by anti-TNF-alpha monoclonal antibody administration in rats with cirrhosis and ascites. J Hepatol 2007;46:797-803.","DOI":"10.1016\/j.jhep.2006.11.018"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2011.10.014"},{"key":"ref93","doi-asserted-by":"crossref","unstructured":"Natarajan SK, Ramamoorthy P, Thomas S, Basivireddy J, Kang G, Ramachandran A, Pulimood AB, Balasubramanian KA. Intestinal mucosal alterations in rats with carbon tetrachloride-induced cirrhosis: changes in glycosylation and luminal bacteria. Hepatology 2006;43:837-846.","DOI":"10.1002\/hep.21097"},{"key":"ref94","doi-asserted-by":"crossref","unstructured":"Bauer TM, Fern&aacute;ndez J, Navasa M, Vila J, Rod&eacute;s J. Failure of Lactobacillus spp. to prevent bacterial translocation in a rat model of experimental cirrhosis. J Hepatol 2002;36:501-506.","DOI":"10.1016\/S0168-8278(02)00003-X"},{"key":"ref95","doi-asserted-by":"crossref","unstructured":"Chiva M, Soriano G, Rochat I, Peralta C, Rochat F, Llovet T, Mirelis B, Schiffrin EJ, Guarner C, Balanz&oacute; J. Effect of Lactobacillus johnsonii La1 and antioxidants on intestinal flora and bacterial translocation in rats with experimental cirrhosis. J Hepatol 2002;37:456-462.","DOI":"10.1016\/S0168-8278(02)00142-3"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.07.019"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e3283537d61"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2008.02.015"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12380"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1586\/17474124.2013.848167"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v20\/i42\/15624.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T19:19:11Z","timestamp":1598469551000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v20\/i42\/15624.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":100,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.v20.i42.15624","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}